Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma

BACKGROUND: Anaplastic thyroid carcinoma (ATC) is a rare but deadly form of thyroid cancer. Kinase inhibitors kinase inhibitors have shown clinical efficacy in the management of ATC, however, eventually these tumors acquire resistance to KI and patients succumb to their disease. Salvage therapy in t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Immunother Cancer
Autori principali: Iyer, Priyanka C., Dadu, Ramona, Gule-Monroe, Maria, Busaidy, Naifa L., Ferrarotto, Renata, Habra, Mouhammed Amir, Zafereo, Mark, Williams, Michelle D., Gunn, G. Brandon, Grosu, Horiana, Skinner, Heath D., Sturgis, Erich M., Gross, Neil, Cabanillas, Maria E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2018
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6042271/
https://ncbi.nlm.nih.gov/pubmed/29996921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0378-y
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi